Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2007 in Parkinson's Disease
NCT00165789Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2005
- Primary completion
- Feb 2006
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perampanel in Parkinson's disease (PD), sponsored by Eisai Co., Ltd.. Started Sep 2005; status: completed.
02
Drugs
perampanel
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00165789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165789.